To earn trust, every day.
Our combination with Organon BioSciences is a transformational step on Schering-Plough’s continuing journey as we build a high-performance company for the long term.
July 1, 2009Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
June 29, 2009Schering-Plough Schedules Conference Call Webcast for 2009 Second Quarter Earnings
June 26, 2009SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
June 23, 2009New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
June 23, 2009Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock
June 22, 2009Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
June 17, 2009The New York Yankees' Mark Teixeira, National Foundation For Cancer Research, and the Makers of COPPERTONE SPORT(R) Launch 'Help Strike Out Sun Damage' Program
June 10, 2009New Analysis Shows Efficacy of Simponi™ (GOLIMUMAB) in Anti-TNF Experienced Rheumatoid Arthritis Patients
June 10, 2009Two-Year Data Show Patients Receiving Simponi™ (GOLIMUMAB) Experienced Sustained Improvements in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondyitis
